Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential topical mometasone furoate versus tapinarof for adult atopic dermatitis
ChiCTR2400093238Phase 4Not yet recruiting
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Nov 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of mometasone and tapinarof in atopic dermatitis (AD) (3 arms), sponsored by Xiangya Hospital, Central South University. Primary endpoint: Total effectiveness rate. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
mometasonetapinarof
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on ChiCTR2400093238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093238.